These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 38140637)

  • 1. Neutralization Determinants on Poxviruses.
    Riccardo V; Pablo GC
    Viruses; 2023 Dec; 15(12):. PubMed ID: 38140637
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Short-term and longer-term protective immune responses generated by subunit vaccination with smallpox A33, B5, L1 or A27 proteins adjuvanted with aluminum hydroxide and CpG in mice challenged with vaccinia virus.
    Xiao Y; Zeng Y; Schante C; Joshi SB; Buchman GW; Volkin DB; Middaugh CR; Isaacs SN
    Vaccine; 2020 Aug; 38(38):6007-6018. PubMed ID: 32741672
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Smallpox vaccines: targets of protective immunity.
    Moss B
    Immunol Rev; 2011 Jan; 239(1):8-26. PubMed ID: 21198662
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Poxvirus Vaccines: Past, Present, and Future.
    Jhancy M
    Adv Exp Med Biol; 2024; 1451():273-287. PubMed ID: 38801584
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protection of mice against the highly pathogenic VV
    Bissa M; Quaglino E; Zanotto C; Illiano E; Rolih V; Pacchioni S; Cavallo F; De Giuli Morghen C; Radaelli A
    Antiviral Res; 2016 Oct; 134():182-191. PubMed ID: 27637905
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic strategies for human poxvirus infections: Monkeypox (mpox), smallpox, molluscipox, and orf.
    De Clercq E; Jiang Y; Li G
    Travel Med Infect Dis; 2023; 52():102528. PubMed ID: 36539022
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Nucleic Acid-Based Orthopoxvirus Vaccine Targeting the Vaccinia Virus L1, A27, B5, and A33 Proteins Protects Rabbits against Lethal Rabbitpox Virus Aerosol Challenge.
    Mucker EM; Golden JW; Hammerbeck CD; Kishimori JM; Royals M; Joselyn MD; Ballantyne J; Nalca A; Hooper JW
    J Virol; 2022 Feb; 96(3):e0150421. PubMed ID: 34851148
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The immunology of smallpox vaccines.
    Kennedy RB; Ovsyannikova IG; Jacobson RM; Poland GA
    Curr Opin Immunol; 2009 Jun; 21(3):314-20. PubMed ID: 19524427
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Smallpox, Monkeypox and Other Human Orthopoxvirus Infections.
    Shchelkunova GA; Shchelkunov SN
    Viruses; 2022 Dec; 15(1):. PubMed ID: 36680142
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Third-generation smallpox vaccines: challenges in the absence of clinical smallpox.
    Meseda CA; Weir JP
    Future Microbiol; 2010 Sep; 5(9):1367-82. PubMed ID: 20860482
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene duplication, gene loss, and recombination events with variola virus shaped the complex evolutionary path of historical American horsepox-based smallpox vaccines.
    Souza ARV; Brinkmann A; Esparza J; Nitsche A; Damaso CR
    mBio; 2023 Oct; 14(5):e0188723. PubMed ID: 37729584
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    Martini M; Behzadifar M; Bragazzi NL; Orsini D
    J Prev Med Hyg; 2023 Jun; 64(2):E209-E214. PubMed ID: 37654859
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and immunogenicity of LC16m8, an attenuated smallpox vaccine in vaccinia-naive adults.
    Kennedy JS; Gurwith M; Dekker CL; Frey SE; Edwards KM; Kenner J; Lock M; Empig C; Morikawa S; Saijo M; Yokote H; Karem K; Damon I; Perlroth M; Greenberg RN
    J Infect Dis; 2011 Nov; 204(9):1395-402. PubMed ID: 21921208
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment and Vaccination for Smallpox and Monkeypox.
    Saalbach KP
    Adv Exp Med Biol; 2024; 1451():301-316. PubMed ID: 38801586
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vaccinia Virus Attenuation by Codon Deoptimization of the A24R Gene for Vaccine Development.
    Lorenzo MM; Nogales A; Chiem K; Blasco R; Martínez-Sobrido L
    Microbiol Spectr; 2022 Jun; 10(3):e0027222. PubMed ID: 35583360
    [TBL] [Abstract][Full Text] [Related]  

  • 16. T-Cell epitope discovery for variola and vaccinia viruses.
    Kennedy R; Poland GA
    Rev Med Virol; 2007; 17(2):93-113. PubMed ID: 17195963
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Global Monkeypox (Mpox) Outbreak: A Comprehensive Review.
    Srivastava S; Kumar S; Jain S; Mohanty A; Thapa N; Poudel P; Bhusal K; Al-Qaim ZH; Barboza JJ; Padhi BK; Sah R
    Vaccines (Basel); 2023 Jun; 11(6):. PubMed ID: 37376482
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunogenicity and protection efficacy of subunit-based smallpox vaccines using variola major antigens.
    Sakhatskyy P; Wang S; Zhang C; Chou TH; Kishko M; Lu S
    Virology; 2008 Feb; 371(1):98-107. PubMed ID: 17950773
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Highly Attenuated Poxvirus-Based Vaccines Against Emerging Viral Diseases.
    Perdiguero B; Pérez P; Marcos-Villar L; Albericio G; Astorgano D; Álvarez E; Sin L; Gómez CE; García-Arriaza J; Esteban M
    J Mol Biol; 2023 Aug; 435(15):168173. PubMed ID: 37301278
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The 1.51-Angstrom structure of the poxvirus L1 protein, a target of potent neutralizing antibodies.
    Su HP; Garman SC; Allison TJ; Fogg C; Moss B; Garboczi DN
    Proc Natl Acad Sci U S A; 2005 Mar; 102(12):4240-5. PubMed ID: 15761054
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.